NEW YORK (Reuters Health) - Many men have some degree of incontinence after prostate surgery, but few are significantly bothered by it, according to a poll at one U.S. hospital.

NEW YORK (Reuters Health) - Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study.

CHICAGO (Reuters) - A mouse virus called XMRV, which has been fingered as a cause of chronic fatigue syndrome, is likely not responsible for the mysterious disease, according to two studies released on Tuesday.

EU trial

More is better when it comes to drinking coffee to ward off the risk of deadly prostate cancer, according to a major US study released by researchers at the Harvard School of Public Health.

Canadian authorities on Tuesday seized hundreds of thousands of counterfeit Viagra and Cialis pills, as well as designer label clothes and accessories from China and destined for sale in Toronto.

NEW YORK (Reuters Health) - The rate of prostate cancer among active-duty U.S. Air Force members has been several times higher in recent years than it was 20 years ago, a new study finds.

NEW YORK (Reuters Life!) - People with diabetes are at higher risk for certain cancers than those without the blood sugar disease, including colon and pancreatic cancer for men and breast cancer for women, according to a U.S. study.

NEW YORK (Reuters Health) - People with diabetes are at higher risk for certain cancers than those without the blood sugar disease, suggests a new study.

NEW YORK (Reuters Health) - There is no convincing evidence that taking high doses of selenium -- a popular dietary supplement -- can prevent cancer, according to a new review.

Surgery appears to be a better treatment option for early prostate cancer than "watchful waiting," particularly for younger patients, according to a Swedish study.

Surgery appears to be a better treatment option for early prostate cancer than "watchful waiting," particularly for younger patients, according to a Swedish study published Thursday.

NEW YORK (Reuters Health) - A new study deflates hopes that certain nutritional supplements could stave off prostate cancer, the second most common cancer in men.

Activists who want to ban male circumcision in San Francisco have taken a step toward putting the issue to a popular vote, sparking outcry from Jewish and Muslim groups.

SAN FRANCISCO (Reuters) - A group opposed to male circumcision said on Tuesday they have collected more than enough signatures to qualify a proposal to ban the practice in San Francisco as a ballot measure for November elections.

SAN FRANCISCO (Reuters) - A group opposed to male circumcision said on Tuesday they have collected more than enough signatures to qualify a proposal to ban the practice in San Francisco as a ballot measure for November elections.

NEW YORK (Reuters Health) - A new study shows nearly half of men feel worse after having their prostate gland removed due to cancer, although three-quarters would do it again given the same circumstances.

NEW YORK (Reuters Health) - For older men with low-risk prostate cancer, a new study adds to evidence that closely watching the tumor instead of immediately treating it may be a reasonable option.

NEW YORK (Reuters Health) - Many men in their 80s get regular blood tests for prostate cancer even though there's no evidence the tests will benefit them, according to a new study.

NEW YORK (Reuters Health) - Testosterone treatment appears to improve the underlying problem in some men with type 2 diabetes, according to a study funded by UK drugmaker ProStrakan.